Connect with us
SIGACHI

Sigachi Industries Limited (SIGACHI) Stock Analysis

Sigachi Industries Limited manufactures microcrystalline cellulose and excipients for pharmaceutical tablet formulations. It supplies pharma excipients to generic and innovator drug makers globally from Indian plants. The company is a leading MCC producer for oral solid dosage forms. It is listed on Indian stock exchanges.

Healthcare › Drug Manufacturers - Specialty & Generic
₹28.50
+0.64% 1W  |  -24.40% 52W
Market Cap
1.1k CR
P/E Ratio
42.6
52W High
₹40.8
52W Low
₹16.6
Div. Yield
0.35%
Beta
0.5
50 DMA
₹30.2
200 DMA
₹24.3
Profit Margin
5.4%
Inst. Own.
0%
Trendline Analysis
⚠️ BREAKDOWN₹45.3₹38.7₹32₹25.3₹18.713 Apr27 May09 Jul26 Aug09 Oct2.0Cr
Fundamentals
Profit & Loss
MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales84.7099.18110.95104.1395.71124.90139.42128.20128.25110.48117.21121.90121.27
Expenses68.3977.7688.3687.8074.69107.67106.2599.65104.14102.96111.49105.49104.76
Operating Profit16.3121.4222.5916.3321.0217.2333.1728.5524.117.525.7216.4116.51
OPM %19.26%21.60%20.36%15.68%21.96%13.80%23.79%22.27%18.80%6.81%4.88%13.46%13.61%
Other Income1.631.111.717.241.6814.642.022.19-117.077.15-0.260.211.00
Interest1.271.791.842.873.162.103.823.333.313.133.134.333.01
Depreciation1.962.522.823.493.153.224.674.744.724.114.184.574.41
Profit before tax14.7118.2219.6417.2116.3926.5526.7022.67-100.997.43-1.857.7210.09
Tax %26.04%17.01%18.02%11.85%22.21%20.83%23.22%28.67%-0.02%-41.59%-98.92%0.78%19.33%
Net Profit10.8815.1216.1015.1712.7621.0120.5116.18-100.9710.53-0.017.658.15
EPS in Rs0.350.490.500.460.400.650.640.35-2.630.280.010.200.18
Growth — CAGR
Metric3Y5Y10Y
Revenue CAGR17.0%20.0%–
Profit CAGR–1.0%–
Shareholding Pattern
Promoters36.69%
FIIs1.25%
Public62.05%
SIGACHI
Holdings Analysis
Key strengths & risk signals
56
Overall
49
Fundamental
64
Technical
Risks (3)
TOO MUCH PUBLIC HOLDING! 51.45% public ownership - higher volatility risk.
POOR YEAR! Stock declined 24.4% in the last year.
RECOVERY MODE! Current price (28.5) above 200-day but below 50-day.
Strengths (4)
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
BULLISH TREND! 50-day average (30.2) is above 200-day average (24.3) - positive signal.
LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 5,775,508 vs down days: 4,271,408. Ratio: 1.35x
Fundamental & Technical Analysis
56Overall
49Fundamental
64Technical
Fundamental Breakdown
Growth Quality
15/30
Revenue CAGR: 16.5% (VERY GOOD, 13/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
3/10
LOW MARGIN! 5.4% profit margin - thin profits.
PEG Valuation
5/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.35% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.23 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 51.45% public ownership - higher volatility risk.
Stability Index
8/10
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (30.2) is above 200-day average (24.3) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (28.5) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
1/10
POOR YEAR! Stock declined 24.4% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 5,775,508 vs down days: 4,271,408. Ratio: 1.35x
RSI
3/5
NEUTRAL! RSI at 43.3 - balanced momentum.
52W Range
3/5
MID RANGE! Trading at 49.2% of 52W range - neutral zone.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 0.6% (1 week), -19.1% (1 month), 25.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.
SIGACHI
Concall / Investor Presentation
Earnings call transcripts & AI summaries
QuarterConcallSummary
Q3FY262026-02-20Concall PDF
Q1FY262025-10-30Concall PDF
Q4FY252026-06-05Concall PDF

Peer Comparison

Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
Industry peers
StockPriceP/EProfit MarginRevenue CAGR 5YProfit CAGR 5Y52W ChangeStock StrengthTrendlineYoY ProfitQoQ ProfitYoY RevenueQoQ Revenue
SIGACHI₹28.5042.65.4%16.5%–-24.4%56 BREAKDOWN-106.8%-11.7%-5.4%-0.5%
LINCOLN₹558.3011.613.9%9.5%6.4%+6.6%57 BREAKDOWN+30.7%+212.1%+15.1%-5.3%
BAJAJHCARE₹320.0046.22.8%-1.8%-28.4%-32.8%44 BOUNCE FROM SUPPORT+16.1%-159.8%+11.3%+8.2%
THEMISMED₹108.6025.112.1%-0.4%-72.8%-16.1%53 BREAKDOWN-273.2%+176.4%-10.9%+13.7%
BAFNAPH₹418.00127.15.5%9.3%-0.7%+152.4%66 BREAKOUT-97.1%-96.3%-23.1%-37.0%
KILITCH₹241.6027.412.7%19.2%42.4%+41.9%84 BREAKOUT-3.3%-80.0%+4.2%-49.9%
ANUHPHR₹82.0018.65.7%13.5%4.3%+4.0%64 BREAKDOWN+37.3%-2.6%+3.9%-4.1%
ZIMLAB₹150.50183.50.9%-2.5%-37.9%+105.9%57 APPROACHING RESISTANCE+110.5%-208.1%+31.2%-10.5%
Data from TradeAlone · Updated daily

No news tagged for SIGACHI yet.